Laminaria ochroleuca extract reduces skin inflammation

Marlène Bonneville,P. Saint-Mézard,J. Benetière,A. Hennino,I. Pernet,A. Denis,J. Nicolas

DOI: https://doi.org/10.1111/j.1468-3083.2006.02111.x

2007-09-01

Journal of the European Academy of Dermatology and Venereology

Abstract:1124 © 2007 The Authors JEADV 2007, 21, 1105–1147 Journal compilation © 2007 European Academy of Dermatology and Venereology and/or alveolar eosinophilia. The known causes of pulmonary eosinophilia include fungi – in particular Aspergillus fumigatus, parasites, various toxins and drugs. The pulmonary eosinophilias of unknown cause include Loffler’s syndrome, acute and chronic eosinophilic pneumonia, the hypereosinophilic syndrome, bronchocentric granulomatosis and pulmonary eosinophilias associated with vasculitis. These candidate disorders were all excluded in our case. Controlling the eosinophilia in blood and lung is important in order to prevent tissue damage caused by eosinophils. Although the number of reported cases is small, we want to recognize that pulmonary eosinophilia in our case may be an indication of immune dysfunction accompanied with EPF. Close follow-up of this patient is needed to see whether systemic involvement occurs in the future. Furthermore a better understanding of eosinophil biology may shed light on the pathophysiology of such associations.